{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
US Approved Rx
(2024)
Source:
BLA761336
(2024)
Source URL:
First approved in 2024
Source:
BLA761336
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2024)
Source:
BLA761391
(2024)
Source URL:
First approved in 2024
Source:
BLA761391
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2024)
Source:
BLA761315
(2024)
Source URL:
First approved in 2024
Source:
BLA761315
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2024)
Source:
BLA761363
(2024)
Source URL:
First approved in 2024
Source:
BLA761363
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2024)
Source:
BLA761306
(2024)
Source URL:
First approved in 2024
Source:
BLA761306
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M020
(2024)
Source URL:
First approved in 2024
Source:
M020
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M020
(2024)
Source URL:
First approved in 2024
Source:
M020
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
pemgarda by Invivyd, Inc
(2024)
Source URL:
First approved in 2024
Source:
pemgarda by Invivyd, Inc
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class:
PROTEIN
